Week 1- Carb Metabolism Flashcards

(56 cards)

1
Q

What does IAPP do? What does PP do?

A

Islet amyloid polypeptide- secreted by beta cells- retards gastric emptying, inhibits glucagon secretion. Pancreatic polypeptide (secreted by PP cells) reduces appetite and food intake.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

What is the relative composition of islets (how much of each cell type present), and what is the distribution

A

60% beta cells (insulin +IAPP) 30% alpha cells (glucagon) <5% PP cells (pancreatic polypeptide) Cells are scattered, but closely associated with microcirculation

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

What is the innervation of the islets and what does it promote?

A

PNS (vagus nerve (ACh)→ promote insulin and glucagon release)

SNS (post-ganglionic celiac (NE)→ inhibit insulin release, promote glucagon)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

What % of liver is glycogen when the liver is saturated?

A

~5%, after this glucose is shunted to FA synthesis and is stored in adipocytes as triglycerides

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

What kind of reeptor is the insulin receptor?

A

tyrosine kinase

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

What are the hormones involved in normal glucose counter regulation?

A

Glucagon and epi are fast acting, GH and cortisol are slow acting

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Etiologies of Diabetes Mellitus

A
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Is beta cell mass dynamic or static througout life? When does diabetes occur?

A

Beta- cell mass is dynamic throughout life (e.g. increases in pregnancy, obesity and insulin resistance)

Diabetes occurs at 20-30% of normal (“critical beta cell mass”)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

What is the pathogenesis of T1DM?

A

Autoimmune destruction of beta cells- during the initial attack they upregulate division and divide faster than a non-diabetic pancreas

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

What is the pathogenesis of T2DM?

A
  • amyloid deposition (plaques of IAPP)
  • macrophage activation –> inflammation (vs. T-cell mediated in T1DM)

peripheral insulin resistance, maybe related to inflammation in adipose tissue

beta-cell exhaustion

glucotoxicity

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

What happens to islets in chronic pancreatitis?

A

Eventually they fibrose and become isolated from blood supply

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

How does cystic fibrosis cause pancreatic fibrosis?

A

Loss of CFTR acidifies pancreatic secretions and proteins precipitate causing ductal obstruction–> fibrosis. This can lead to DM by bystander damage

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

How much does DM shorten life expectancy by, on average?

A

15 years!

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

How does the clinical presentation differ between T1DM and T2DM?

A

T1DM

  • usually younger, lean, acute, ketosis prone, may not have FHx

T2DM

  • usually older, progression presentation, overweight, not ketosis prone with a FHx of DM
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Possible presenting symptoms of DM

A

Sx of DM
• thirst
• polyuria
• recent weight gain or loss
• extreme fatigue
• blurred vision
• recurring infections
• cuts/bruises slow to heal
• tingling or numbness in hands or feet
• ED in males

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Diagnostic criteria for DM

A

Diagnostic criteria
• Any of the following with symptomatic hyperglycemia:
o FPG > 7
o A1C > 6.5.%
o 2hPG in OGTT >11.1
o a random PG of >11.1
• Any of the above, without Sx, repeated on another day

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

What other autoimmune conditions must be monitored for in someone with T1DM?

A
  • Hashimoto’s thyroiditis (hypo)
  • Grave’s (hyper)
  • Addison’s (adrenal hypofunction)
  • Coeliac
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

Why is it important to try and classify T1DM vs. T2DM if you are unsure?

A

T1DM will benefit from early induction of insulin (don’t need to try oral hypoglycemics)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

What are conditions associated with DM?

A
  • obstructive sleep apnea
  • polycystic ovarian syndrome
  • acnthosis nigricans
  • HIV infection
  • psych disorders
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

Screening guidelines for DM

A

Screening guidelines:
• Everyone over 40, every 3 yrs if normal results
• Younger for
o High risk ethnic group (FN, Hispanic, Asian, African descent)
o 1st deg relative with DM
o previous gestational
o CV risk factors
o Drugs (atypical antipsychotics, ARVs, glucocorticoids)
o Associated diseases (PCOS, acantosis nigricans, OSA, psych, HIV)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

Precipitants of diabetic ketoacidosis and hyperosmolar hyperglycemic state

A

The I’s

  • Insulin deficient (failure to take enough)
  • Iatrogenesis (e.g. glucocorticoids)
  • Infection (this increases epi, cortisol)
  • Inflammation (e.g. pancreatitis, cholecystitis)
  • Ischemia/Infarction (MI, gut, cerebral)
  • Intoxication (drugs, EtOH)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
22
Q

What would you expect on the following lab tests for a pt with DKA?

  • lytes (Na, K, HCO3
  • pH
  • Urea
  • Creatinine
  • Glucose
  • pCO2
A

lytes

  • pseudohyponatremia: water pulled osmotically from intracellular compartment dilutes the sodium
  • normal to hyperkalemia, with depletion of total body potassium because acidosis pulls K out of cells and it is subsequently lost in osmotic diuresis
  • HCO3- is low because of the ketoacidosis

pH

  • acidic because of the ketoacidosis

Urea

  • high…don’t know why

Creatinine

  • high…volume reduction decreases GFR

Glucose

  • high because a relative or absolute lack of insulin promotes gluconeogenesis, glycogenolysis and prevents uptake into cells –> hyperglycemia

pCO2

  • low, because you’re blowing off CO2 in an attempt to correct the metabolic acidosis
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
23
Q

What are some differentiating factors between DKA and HHS?

A

• Differentiating factors:
o No ketoacidosis in HHS, negative ketones
o HHS tends to have higher blood glucose
o HHS tends to have more profound volume contraction → higher POsm

And, DKA is T1DM while HHS is more elderly T2DM

24
Q

Management of DKA and HHS

A

o Management
• Restore volume with isotonic saline
• Bicarb if pH < 7.0 (seen in DKA only)
• Bolus–> continuous infusion insulin
• Replace potassium
• Go slow and monitor POsm, Na, K, HCO3, PO4, glucose !

25
What is the pathogenesis of diabetic complications?
* **non-enzymatic glycosylation** of protein amino groups, nucleic acids, lipids → advanced glycosylation end-products→ accumulation and undesired receptor binding * **intracellular hyperglycemia** in tissues that don’t require insulin for entry → metabolized to sorbitol and fructose→ osmotic cell injury (impaired ion pumps, swelling)
26
What are the renal complications of DM
1. glomerulosclerosis 2. lesions (atherosclerosis, arteriosclerosis) 3. infection 4. necrotizing papillitis 5. autonomic neuropathy
27
What are the long-term complications of DM (systems level)? When do they appear?
1. vascular (micro and macro) 2. Renal 3. neuropathy 4. retinopathy 5. skin 6. Infectious diseases Usually develop 10-15 yrs following onset, but can be delayed by tight blood sugar control
28
What is this?
Diabetic amyotrophy (diabetic polyradiculopathy)
29
What is this?
necrobiosis lipoidica diabeticorum
30
What is this?
Granuloma annulare
31
What are the classes of drugs used to treat DM?
* secretagogue * sulfonylureas * meglitinides * alpha-glucosidase inhibitors * biguanides (metformin) * thiazolidinediones * Incretins * GLP-1 analog * DPP-4 inhibitor * SGLT-2 inhibitor * Insulin (short, intermediate, long acting)
32
Who is most likely to present with hypoglycemia?
insulin treated diabetics, neonates
33
What is Whipple's triad?
Whipple’s triad • Symptoms • Lab comfirmation (\<2.5 mM) • Relief of Sx with glucose
34
Hypoglycemia work-up results (glucose levels, insulin levels, c-peptide levels, ketones) for different causes of hypoglycemia
35
What is the cellular pathway for insulin release? Where does sulfonylurea act?
sulfonylurea acts on the SUR part of the KATP channel
36
Lactic acidosis and ketoacidosis can be seen in diabetics. Where does the lactate come from?
Decreased tissue perfusion (dehydration + peripheral vascular changes) means they rely more on anaerobic metabolism
37
Why might you see hypokalemia during the treatment of DKA?
1. administered insulin stimulates K to enter cells 2. K loss in the urine because volume contraction (osmotic diuresis) --\> RAAS--\> aldosterone release--\> K wasting
38
What is acanthosis nigricans indicative of?
Insulin resistance
39
What are the possible complications of infants born to a diabetic mother?
a large for gestational age infant congenital anomalies neonatal hypoglycemia (early insulin production) neonatal polycythemia (increased epo due to relative hypoxemia, from elevated metabolic rate of infant)
40
MOA of secratagogues
SUlfonylureas bind the SUR part of KATP channel and help keep it closed so more insulin can be released Meglinitides do the same but bind a different part
41
Classification of hypoglycemia in neonates
Classification of hypoglycemia in neonates: Transient * Prematurity * Maternal DM * Transient ketotic hypoglycemia • Persistent * Hormonal * Hyperinsulinemia * Panhypopit * GH deficiency * ACTH deficiency * Adrenal insufficiency * Glycogenolysis enzyme defieciency * Gluconeogeneogenesis disorder * Fatty Acid Oxidation disorders
42
WHat is the MOA for alpha-glucosidase inhibitors?
prevent carbs from being absorbed
43
What is the MOA of biguanides?
e.g. metformin "Insulin sensitizers" they increase muscle glucose use and decrease hepatic glucose output
44
What is the MOA of thiazolidinediones?
PPAR-gamma activators...
45
What is the mechanism of incretins?
GLP-1 agonist...GLP stimulates insulin release DPP inhibitors (keep endogenous GLP from being broken down)
46
Which oral hypoglycemics promote weight loss?
Weight loss: * GLP-1 agonist * DPP-4 inbitors (weight neutral or weight loss) * alpha-glucosidase inhibitors
47
Priniciples of treatment in T2DM
* try and acheive glycemic target in 3-6 months * if A1C \>8.5, start metformin * if symptomatic hyperglycemia start insulin +/- metformin
48
What do carnitine levels tell you in the context of pediatric hypoglycemia?
low plasma cartinine could indicate a FA oxidation disorder
49
What is the MOA of diazoxide and when is it used?
It is a potassium channel activator, It is used in congenital hyperinsulinemia to block insulin secretion (which requires the KATP channel to be inactive)
50
Where does somatostatin act on a beta-cell?
It blocks the voltage gated calcium channel that needs to open for the insulin granules to be released
51
How much glucose do normal, healthy infants require to maintain euglycemia
6-8 mg/kg/min
52
What are the rate limiting enzymes of gluconeogenesis?
* PEP carboxykinase * Fructose 1,6 diphosphatase * G6 phosphatase *
53
What is Beckwith-Wiedemann Syndrome?
pediatric overgrowth disorder. can be a cause of neonatal hypoglycemia. 1:12 000 ish
54
What controls insulin secretion?
55
Prevalence of T1DM...what is ICA
t1DM= 1/400 ICA: islet cells antibodies...T1DM is immune mediated
56
What happens to the islets of IDM
beta-cell hyperplasia